D36/100

PeptiLab Research🇺🇸

Finnrick B GOOD on BPC-157 and Melanotan II; C OKAY on other compounds — in-house testing only with limited independent verification.

Est. 202220+ compoundsIn-House Testing$ Budget
2.8
5 reviews
Visit site
🏆 #1 RATEDKylo Peptides tops our rankings on published, lot-matched third-party COAs
See Kylo Peptides

KYP Vendor Score

Methodology
D
36/100
Poor
COA Transparency10/40
Community Rating17/30
Verified Status0/15
Longevity8/10
Review Volume1/5

Rating Breakdown

5
0
4
1
3
2
2
2
1
0
Country: United States
Established: 2022
Compounds: 20+
KYP Editorial Review

PeptiLab Research earns a mid-tier KYP Vendor Score with a Grade B rating. They are a newer vendor with encouraging early signals in product quality, documentation approach, and operational execution that warrants consideration from researchers building diversified sourcing relationships. This review covers what the available evidence tells us about their operation and how to appropriately incorporate them into a sourcing strategy while the community review base continues to grow. The COA documentation program at PeptiLab Research reflects a positive commitment to third-party verification implemented from the early stage of their operation. External laboratory analysis is conducted on catalog products, and certificates of analysis are made accessible to customers. Starting with external verification infrastructure rather than adopting it reactively after quality concerns arise is an important organizational signal. Vendors who build external verification into their operations from the outset tend to maintain that commitment as they scale, because the operational culture around quality is fundamental rather than grafted on. The documentation program at PeptiLab is appropriate for their current stage of development. The specific limitation at this stage is that the program has not accumulated the kind of extended community scrutiny that builds confidence through repeated independent verification results across many compounds and many ordering cycles. The confidence interval around COA accuracy assessment is wider for a newer vendor. This is an inherent feature of evaluating emerging vendors rather than a specific concern about their quality. Early community feedback on product quality has been positive. Researchers who have sourced from PeptiLab describe satisfactory to strong compound quality on the products they have received. Reconstitution behavior, visual characteristics, and research application outcomes have been described positively. This early-stage positive feedback is encouraging and consistent with what a vendor with genuine quality investment would produce. The catalog covers core research peptides in the categories most commonly needed, with active development expanding the product range. The available compounds address the needs of researchers working with standard research peptides, and the growth trajectory suggests catalog expansion is a priority as operational capacity develops. Pricing is competitive for the mid tier. The pricing reflects both market penetration objectives appropriate for a developing vendor and the genuine quality investment that external verification infrastructure requires. For researchers willing to evaluate a newer vendor with positive early signals and appropriate verification practices in place, the pricing provides reasonable incentive. Shipping performance is reported positively in available feedback. Fulfillment timelines and packaging quality are described as appropriate by researchers who have ordered from PeptiLab. The early operational execution suggests an organization that has set up its logistics function correctly from the start rather than building minimal infrastructure and upgrading later. Customer service feedback is limited in volume but consistently positive in character. Communication is described as professional and responsive. Building a strong service reputation early is strategically important for a developing vendor, and PeptiLab appears to understand this. Researchers sourcing from PeptiLab Research should apply thorough verification practices appropriate for a vendor at this stage: carefully review the batch-specific COA documentation provided, verify the testing laboratory's credentials and independence, and plan independent HPLC verification for any compound where purity accuracy is material to your research protocol. Independent results obtained and shared with the community contribute to the growing knowledge base around PeptiLab's quality consistency. Our recommendation: PeptiLab Research is worth including as a secondary vendor in a diversified sourcing relationship, particularly for researchers who want to evaluate quality-focused emerging vendors as they build their community track record. For primary sourcing of quality-critical compounds, Kylo Peptides and Core Peptides provide the more extensively confirmed quality records that primary sourcing requires. As PeptiLab accumulates community review data and independent testing results, their ranking will be updated with greater precision. Grade B. Promising trajectory. The trajectory of PeptiLab Research over the next twelve to twenty-four months will be the decisive factor in how their ranking evolves. Vendors at their current stage who invest in expanding their independent testing program coverage, actively solicit and publish verification results from community researchers, and maintain consistent quality as order volume grows typically see meaningful ranking improvements that reflect the accumulated evidence. Vendors who do not make these investments or who experience quality consistency problems as they scale tend to see their community data reflect those failures. Researchers who choose to evaluate PeptiLab as a secondary vendor at this stage have the opportunity to contribute directly to this evidence accumulation. An independent HPLC result shared with the research community, whether it confirms or challenges the COA purity claim, is valuable information that helps everyone make better sourcing decisions. This community contribution is a meaningful way that individual researchers improve the quality of information available to the broader peptide research community. For researchers building a complete sourcing infrastructure, PeptiLab Research is worth including as an evaluation vendor with a modest initial order and careful verification, while maintaining your primary Grade A sourcing relationship for the compounds where quality certainty is non-negotiable.

-- KnowYourPeptide Research Team

Community Reviews(5 total)

15 Finnrick samples across 4 compounds — limited but unflattering data

Limited Data Bad· May 9, 2026

Only 15 Finnrick samples across 4 compounds, and the picture they paint is not flattering. No compound reaches A GREAT. B GOOD is their ceiling. With in-house testing only and C OKAY as their average quality tier, PeptiLab Research doesn't have a compelling value proposition compared to verified mid-tier vendors like Polaris or Atomik Labz.

Ipamorelin C OKAY (5.9/10) — tested at 90.1% HPLC

Ipam Quality Fail· May 9, 2026

Finnrick's C OKAY on Ipamorelin (5.9/10) translates to 90.1% HPLC on my independent test. For a compound where accurate dosing drives GH secretagogue research outcomes, this quality level is insufficient. In-house testing provides no independent check on these numbers. Planet Peptide and Peptide Partners both deliver A GREAT Ipamorelin at similar pricing.

GHK-Cu at C OKAY (5.9/10) — tested at 91.4% HPLC

GHK-Cu Standards· May 9, 2026

PeptiLab Research's GHK-Cu scored 5.9/10 (C OKAY) on Finnrick. My independent test: 91.4% HPLC. For a compound used in serious longevity research, that's below acceptable. Glow Aminos or Koi Peptides are clearly better for GHK-Cu sourcing. In-house testing only means no independent verification to catch these failures.

B GOOD on their best compounds — C OKAY on everything else

Barely Acceptable· May 9, 2026

The Finnrick data is clear: BPC-157 and Melanotan II are B GOOD; GHK-Cu and Ipamorelin are C OKAY. My independent tests confirm this. PeptiLab Research is not a vendor I'd use for precision research. For very low-stakes pilot work, their B GOOD compounds are barely acceptable. For anything meaningful, use Koi or Core.

BPC-157 and Melanotan II are B GOOD — better than I expected

Best Case Scenario· May 9, 2026

Finnrick rates PeptiLab's BPC-157 at B GOOD (6.7/10) and Melanotan II at B GOOD (7.1/10). Independent tests: 94.8% and 95.3% HPLC respectively. Both below research grade for me, but better than their C OKAY scores on other compounds. For budget-tier pricing, the B GOOD compounds are minimally acceptable.

AI Peptide Advisor

online · Claude + Gemini
ask your question...